These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 12813006
1. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Moreno-Manzano V, Mampaso F, Sepúlveda-Muñoz JC, Alique M, Chen S, Ziyadeh FN, Iglesias-de la Cruz MC, Rodríguez J, Nieto E, Orellana JM, Reyes P, Arribas I, Xu Q, Kitamura M, Lucio Cazana FJ. Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006 [Abstract] [Full Text] [Related]
2. Retinoids regulate the repairing process of the podocytes in puromycin aminonucleoside-induced nephrotic rats. Suzuki A, Ito T, Imai E, Yamato M, Iwatani H, Kawachi H, Hori M. J Am Soc Nephrol; 2003 Apr; 14(4):981-91. PubMed ID: 12660332 [Abstract] [Full Text] [Related]
3. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Jones CL, Buch S, Post M, McCulloch L, Liu E, Eddy AA. Am J Pathol; 1992 Dec; 141(6):1381-96. PubMed ID: 1281619 [Abstract] [Full Text] [Related]
4. Nicorandil protects podocytes via modulation of antioxidative capacity in acute puromycin aminonucleoside-induced nephrosis in rats. Yamanaka M, Tamura Y, Kuribayashi-Okuma E, Uchida S, Shibata S. Am J Physiol Renal Physiol; 2023 Feb 01; 324(2):F168-F178. PubMed ID: 36454699 [Abstract] [Full Text] [Related]
5. Protection of alpha(3) integrin-mediated podocyte shape by superoxide dismutase in the puromycin aminonucleoside nephrosis rat. Kojima K, Matsui K, Nagase M. Am J Kidney Dis; 2000 Jun 01; 35(6):1175-85. PubMed ID: 10845833 [Abstract] [Full Text] [Related]
6. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats. Kim BS, Park HC, Kang SW, Choi KH, Ha SK, Han DS, Lee HY. Yonsei Med J; 2005 Feb 28; 46(1):141-8. PubMed ID: 15744817 [Abstract] [Full Text] [Related]
7. The relationship between glomerular function and podocyte structure of pre-proteinuria and acute nephrosis in puromycin aminonucleoside-induced rat models: a comparative electron microscopic study. Seçkin İ, Uzunalan M, Pekpak M, Köktürk S, Sönmez HA, Güngör ZB, Demirkiran ÖD, Saygi Hİ, Yaprak Saraç E. Rom J Morphol Embryol; 2017 Feb 28; 58(3):823-830. PubMed ID: 29250660 [Abstract] [Full Text] [Related]
8. Tolvaptan, a selective oral vasopressin V2 receptor antagonist, ameliorates podocyte injury in puromycin aminonucleoside nephrotic rats. Okada T, Sakaguchi T, Hatamura I, Saji F, Negi S, Otani H, Muragaki Y, Kawachi H, Shigematsu T. Clin Exp Nephrol; 2009 Oct 28; 13(5):438-446. PubMed ID: 19452240 [Abstract] [Full Text] [Related]
9. CXCL10 induces the recruitment of monocyte-derived macrophages into kidney, which aggravate puromycin aminonucleoside nephrosis. Petrovic-Djergovic D, Popovic M, Chittiprol S, Cortado H, Ransom RF, Partida-Sánchez S. Clin Exp Immunol; 2015 May 28; 180(2):305-15. PubMed ID: 25561167 [Abstract] [Full Text] [Related]
10. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis. Nakayama K, Natori Y, Sato T, Kimura T, Sugiura A, Sato H, Saito T, Ito S, Natori Y. J Lab Clin Med; 2004 Feb 28; 143(2):106-14. PubMed ID: 14966466 [Abstract] [Full Text] [Related]
11. A scanning and transmission electron microscopic comparison of puromycin aminonucleoside-induced nephrosis to hyperalbuminemia-induced proteinuria with emphasis on kidney podocyte pedicel loss. Andrews PM. Lab Invest; 1977 Feb 28; 36(2):183-97. PubMed ID: 839733 [Abstract] [Full Text] [Related]
12. Re-evaluation of foot process effacement in acute puromycin aminonucleoside nephrosis. Inokuchi S, Shirato I, Kobayashi N, Koide H, Tomino Y, Sakai T. Kidney Int; 1996 Oct 28; 50(4):1278-87. PubMed ID: 8887289 [Abstract] [Full Text] [Related]
13. Sialic acid supplementation ameliorates puromycin aminonucleoside nephrosis in rats. Pawluczyk IZ, Najafabadi MG, Brown JR, Bevington A, Topham PS. Lab Invest; 2015 Sep 28; 95(9):1019-28. PubMed ID: 26121320 [Abstract] [Full Text] [Related]
14. Increased expression of CD54, CD18, MHC class II molecules, and proliferating cell nuclear antigen in acute puromycin aminonucleoside nephrosis. Fernandez L, Romero M, Rincón J, Mosquera J. Nephron Exp Nephrol; 2003 Sep 28; 94(2):e55-65. PubMed ID: 12845231 [Abstract] [Full Text] [Related]
15. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice. Shimo T, Adachi Y, Yamanouchi S, Tsuji S, Kimata T, Umezawa K, Okigaki M, Takaya J, Ikehara S, Kaneko K. Am J Nephrol; 2013 Sep 28; 37(4):302-9. PubMed ID: 23548793 [Abstract] [Full Text] [Related]
16. GLEPP1 receptor tyrosine phosphatase (Ptpro) in rat PAN nephrosis. A marker of acute podocyte injury. Kim YH, Goyal M, Wharram B, Wiggins J, Kershaw D, Wiggins R. Nephron; 2002 Apr 28; 90(4):471-6. PubMed ID: 11961407 [Abstract] [Full Text] [Related]
17. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases. Dong N, Meng L, Xue R, Yu M, Zhao Z, Liu X. Int Urol Nephrol; 2017 Aug 28; 49(8):1489-1506. PubMed ID: 28528353 [Abstract] [Full Text] [Related]
18. Key molecular events in puromycin aminonucleoside nephrosis rats. Guan N, Ding J, Deng J, Zhang J, Yang J. Pathol Int; 2004 Sep 28; 54(9):703-11. PubMed ID: 15363039 [Abstract] [Full Text] [Related]
19. Calcineurin inhibitors cyclosporin A and tacrolimus protect against podocyte injury induced by puromycin aminonucleoside in rodent models. Shen X, Jiang H, Ying M, Xie Z, Li X, Wang H, Zhao J, Lin C, Wang Y, Feng S, Shen J, Weng C, Lin W, Wang H, Zhou Q, Bi Y, Li M, Wang L, Zhu T, Huang X, Lan HY, Zhou J, Chen J. Sci Rep; 2016 Sep 01; 6():32087. PubMed ID: 27580845 [Abstract] [Full Text] [Related]
20. An ultrastructural study of the glomerular slit diaphragm in aminonucleoside nephrosis. Ryan GB, Rodewald R, Karnovsky MJ. Lab Invest; 1975 Nov 01; 33(5):461-8. PubMed ID: 1186127 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]